Protecting the Gut Microbiome

Synthetic Biologics is pioneering cutting-edge microbiome science designed to preserve the microbiome to protect and restore the health of patients.

Our two lead programs in late-stage clinical development are SYN-004 (ribaxamase), designed to protect the natural gut microbiome to prevent antibiotic-mediated primary C. difficile infection (CDI), pathogenic overgrowth and the emergence of antimicrobial resistance (AMR) and SYN-010, designed to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C).